Your browser doesn't support javascript.
loading
WHO target product profiles for TB preventive treatment.
Den Boon, S; Lienhardt, C; Zignol, M; Schwartzman, K; Arinaminpathy, N; Campbell, J R; Nahid, P; Penazzato, M; Menzies, D; Vesga, J F; Oxlade, O; Churchyard, G; Merle, C S; Kasaeva, T; Falzon, D.
Afiliación
  • Den Boon S; Global Tuberculosis Programme, World Health Organization (WHO), Geneva, Switzerland.
  • Lienhardt C; Unité Mixte Internationale TransVIHMI, Unité mixte internationale 233, Institut de recherche pour le développement, Unité 1175, Université de Montpellier, Institut de Recherche pour le Développement (INSERM), Montpellier, France, Epidemiology and Population Health, Department of Infectious Disease E
  • Zignol M; Global Tuberculosis Programme, World Health Organization (WHO), Geneva, Switzerland.
  • Schwartzman K; McGill International Tuberculosis Centre, McGill University, Montréal, QC, Canada.
  • Arinaminpathy N; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Campbell JR; Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, London, UK.
  • Nahid P; Center for Tuberculosis, University of California, San Francisco, CA, USA.
  • Penazzato M; Department of Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, WHO, Geneva, Switzerland.
  • Menzies D; McGill International Tuberculosis Centre, McGill University, Montréal, QC, Canada.
  • Vesga JF; MRC Centre for Global Infectious Disease Analysis, Imperial College London, London, UK.
  • Oxlade O; McGill International Tuberculosis Centre, McGill University, Montréal, QC, Canada.
  • Churchyard G; The Aurum Institute, Johannesburg, South Africa, School of Public Health, University of Witwatersrand, Johannesburg, South Africa.
  • Merle CS; Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland.
  • Kasaeva T; Global Tuberculosis Programme, World Health Organization (WHO), Geneva, Switzerland.
  • Falzon D; Global Tuberculosis Programme, World Health Organization (WHO), Geneva, Switzerland.
Int J Tuberc Lung Dis ; 26(4): 302-309, 2022 04 01.
Article en En | MEDLINE | ID: mdl-35351234
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2022 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tuberculosis / Mycobacterium tuberculosis Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Año: 2022 Tipo del documento: Article País de afiliación: Suiza